🇺🇸 FDA
Patent

US 11752130

Carboxylated psilocybin derivatives and methods of using

granted A61KA61K31/404A61P

Quick answer

US patent 11752130 (Carboxylated psilocybin derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enveric Biosciences Canada Inc.
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/404, A61P, A61P25/00, A61P25/18